跳至主要内容
临床试验/NCT04310956
NCT04310956已完成不适用

A Multi-center, Randomized Controlled Trial to Evaluate the Effectiveness and Safety of Y-Knot All-suture Anchor in Ankle Ligaments Injury Repair

ConMed Linvatec Beijing4 个研究点 分布在 1 个国家目标入组 148 人开始时间: 2019年12月23日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
148
试验地点
4
主要终点
improvement of AOFAS score

研究概览

简要总结

Purpose of this study is to evaluate the effectiveness and safety of Y-Knot all-suture anchor by comparing patients' clinical outcome after ankle ligaments repair surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or Female, no less than 18 years old;
  • Patient was diagnosed as Collateral Ligament injury or Achilles tendon injury based on MRI or X-Ray who need to conduct foot&ankle repair surgery by investigator;
  • Patient willing to sign a written consent form participating in this study;
  • Subject is able to understand study, willing to comply the study procedures, and willing to return to hospital for follow-up up to 6 months postoperative;
  • Life expectancy is more than 2 years post-operationally;

排除标准

  • Conducted surgery at index ankle and possibly influence the outcome evaluation;
  • Bilateral ankle surgery;
  • Suffering concurrent ankle disease that may leads to a surgery during the study phase;
  • known or suspected allergies to implant and/or instrument materials;
  • pathological conditions of bone which would adversely affect the anchor fixation; with concurrent severe injury at index leg that may influence the outcome evaluation; Severe obesity;
  • With concurrent disease that may influence the index ankle function;
  • Patients with active sepsis or infection;
  • With concurrent disease that may influence the stability of device and rehabilitation;
  • Immune suppression, impairment of immune function, or autoimmune disease;
  • Pregnant or lactating women;
  • Known noncompliance or lost follow-up risk;
  • Participated other drug, biologic, or device clinical trial 12 months before enrollment;
  • Alcohol or drug abuser;
  • Other inappropriate condition based on investigator determination;

结局指标

主要结局

improvement of AOFAS score

时间窗: From pre-operation to 6 months postoperative

次要结局

  • improvement of AOFAS score(From pre-operation to 3 months postoperative)
  • ligament injury recurrences(up to 6 months postoperative)
  • secondary surgery(up to 6 months postoperative)
  • Improvement of VAS score(From pre-operation to 3 and 6 months postoperative)

研究者

发起方
ConMed Linvatec Beijing
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验